Products Category
Antibody-drug Conjugate/ADC Related
Trk Receptor
Contact Us
Tel: 0519-85788828
Fax: 0519-89960117
Mobile: 13775037613
E-mail: sales@chemrenpharm.com
Add: 169 Qingliang Road, Changzhou, Jiangsu,China
QQ:
2500035664
|
| Details: |
Description of:GSK1904529A
GSK1904529A selectively inhibits IGF-IR and IR with IC50s of 27 and 25 nmol/L, respectively.IC50s for GSK1904529A in tumor cell lines ranged from 35 nmol/L to >30 umol/L. The tumor histologic types showing the greatest sensitivity to this compound were Ewing's sarcoma and multiple myeloma, where IC50s in three of five Ewing's sarcoma cell lines were <100 nmol/L and IC50s in five of eight multiple myeloma cell lines were <200 nmol/L. Theoretical analysis:GSK1904529A M.Wt: 851.96 Formula: C44H47F2N9O5S Solubility: Soluble in DMSO at 10 mmol/L Purity: >99% Storage: -20C 2 years CAS No: 1089283-49-7 Availability and price:GSK1904529A Pakage：25mg/50mg/100mg/250mg/500mg/1g/5g Stock : in stock We offer significant discount for larger quantity order. For quotation, question, and order, please send email to : sales@chemrenpharm.com Quality control data: Quality Control by H-NMR,C-NMR,LC-MS,HPLC. Product will be shipped with supporting analytical data. Fast delivery about 4-5 working days |
| Related Products : |
|
|
|
|
||||||||
|
|
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian